Home >> Research Area >> Meglumine

Meglumine

CAS# 6284-40-8

Meglumine

Catalog No. BCC4795----Order now to get a substantial discount!

Product Name & Size Price Stock
Meglumine: 5mg $12 In Stock
Meglumine: 10mg Please Inquire In Stock
Meglumine: 20mg Please Inquire Please Inquire
Meglumine: 50mg Please Inquire Please Inquire
Meglumine: 100mg Please Inquire Please Inquire
Meglumine: 200mg Please Inquire Please Inquire
Meglumine: 500mg Please Inquire Please Inquire
Meglumine: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Meglumine

Number of papers citing our products

Chemical structure

Meglumine

3D structure

Chemical Properties of Meglumine

Cas No. 6284-40-8 SDF Download SDF
PubChem ID 4049 Appearance Powder
Formula C7H17NO5 M.Wt 195.21
Type of Compound N/A Storage Desiccate at -20°C
Synonyms Meglumin; Methylglucamin; Methylglucamine
Solubility H2O : 50 mg/mL (256.13 mM; Need ultrasonic)
DMSO : ≥ 50 mg/mL (256.13 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 6-(methylamino)hexane-1,2,3,4,5-pentol
SMILES CNCC(C(C(C(CO)O)O)O)O
Standard InChIKey MBBZMMPHUWSWHV-UHFFFAOYSA-N
Standard InChI InChI=1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of Meglumine

DescriptionMeglumine is an amino sugar derived from sorbitol. Target: Others Meglumine is often used as an excipient in pharmaceuticals and in conjunction with iodinated compounds in contrast media such as diatrizoate meglumine and iodipamide meglumine.[1]

References:
[1]. http://www.chemicalland21.com/lifescience/phar/N-METHYL-D-GLUCAMINE.htm

Meglumine Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Meglumine Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Meglumine

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 5.1227 mL 25.6134 mL 51.2269 mL 102.4538 mL 128.0672 mL
5 mM 1.0245 mL 5.1227 mL 10.2454 mL 20.4908 mL 25.6134 mL
10 mM 0.5123 mL 2.5613 mL 5.1227 mL 10.2454 mL 12.8067 mL
50 mM 0.1025 mL 0.5123 mL 1.0245 mL 2.0491 mL 2.5613 mL
100 mM 0.0512 mL 0.2561 mL 0.5123 mL 1.0245 mL 1.2807 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Meglumine

Meglumine

Featured Products
New Products
 

References on Meglumine

Meglumine antimoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.[Pubmed:28111133]

Acta Trop. 2017 May;169:30-42.

Currently, the treatment of leishmaniasis is increasingly insufficient as current antileishmanial drugs have many disadvantages such as toxic side effects, high cost, and growing drug resistance. In order to overcome these disadvantages, researchers have recently focused on combination therapy by using pentavalent antimonials in conjunction with other antileihmanial compounds. Our previous study found that TiO2@Ag nanoparticles (TiAgNps) demonstrated significant antileishmanial effects. However, a lethal dose of TiAgNps on L. topica promastigotes was found to be toxic for macrophage cells. Moreover, non-toxic concentrations of TiAgNps were ineffective in inhibiting L. topica promastigotes and amastigotes. Thus, we propose the use of TiAgNps in combination with other antileishmanial compounds like Meglumine antimoniate (MA) at non-toxic concentrations, which may increase the efficacies of both agents and decrease their toxicities. Therefore, the aim of this study was to determine in vitro and in vivo antileishmanial efficacies of TiAgNps-MA combinations at non-toxic concentrations and develop a new approach for treatment that lowers the toxicities of pentavalent antimonials to minimal levels and enhances their effectiveness. In vitro screening was performed on L. topica promastigote and amastigote-macropage culture by using MTT assay to determine proliferation, perform infection index analysis, and to conduct a Griess reaction for nitric oxide production, while in vivo antileishmanial assays were applied on Balb/c mice with CL models. The results demonstrated that combinations including TiAgNps and MA at non-toxic concentrations were highly efficacious against both promastigotes and amastigotes, while MA application alone did not show any inhibitory effects. It was determined that combination applications decreased the proliferation of L. topica promastigotes 2- to 5-fold in contrast to use of MA alone, and was dependent on concentrations. Moreover, the use of combinations led to inhibition of L. topica amastigotes at rates ranging between 80% and 95%. Additionally, combinations were found to decrease metabolic activities of each form of the parasite at ranges between 7- to 20-fold, causing programmed-cell death and stimulation of macrophages for intensive production of nitric oxide, which is accepted as an important antileishmanial agent (p<0.05). Furthermore, Sigma FIC analysis demonstrated that the tested combinations composed little additive, but mostly synergistic effects for inhibition of promastigotes and amastigotes. According to in vivo screening results, the combinations displayed high antileishmanial activities by successfully healing lesions and significantly reducing parasite burdens. Combined, these results show that TiAgNps-MA combinations were much more effective than use of MA alone at non-toxic concentrations and they possess high potential for development of new antileishmanial drugs to fight against leishmaniasis.

Effect of hydroalcoholic extract of Echinacea purpurea in combination with meglumine antimoniate on treatment of Leishmania major-induced cutaneous leishmaniasis in BALB/c mice.[Pubmed:28251109]

Int J Appl Basic Med Res. 2017 Jan-Mar;7(1):53-56.

CONTEXT: Progressive resistance of Leishmania parasite to available drugs including, Meglumine antimoniate, has been reported from various regions of the world, especially Iran. AIMS: This study was conducted to evaluate the effect of hydroalcoholic extract of Echinacea purpurea in a combination therapy with glucantime in the treatment of cutaneous leishmaniasis caused by Leishmania major. MATERIALS AND METHODS: Hydroalcoholic extract of E. purpurea was prepared from the plant. Amastigote form of L. major was inoculated to the tail base of thirty mice. After their tails became wounded, mice were divided into six groups. The first group was used as control and the second group received 100 mg/kg of Echinacea extract (orally). The third group was treated by Meglumine antimoniate with dose of 20 mg/kg. Combination therapy was used for group four, five, and six where the mice received a different concentration of extract (100-200 mg/kg) and glucantime (10-20 mg/kg). The size of the cutaneous lesion on tail base was measured regularly. Findings were analyzed by SPSS software and using Kruskal-Wallis test. RESULTS: The sizes of the lesion were increased in all mice of control group by the time. The mean size of lesions in mice receiving the extract and/or receiving the extract along with Meglumine antimoniate was lower than those of control mice, but the differences were not statistically significant (P > 0.05). On the other hand, the differences between the group of mice which received Meglumine antimoniate alone, and the rest of groups were statistically significant (P < 0.05). CONCLUSION: E. purpurea extract in doses which have been used in this study and combination with Meglumine antimoniate was not much effective against L. major in BALB/C mice.

Description

Meglumine is an amino sugar derived from sorbitol.

Keywords:

Meglumine,6284-40-8,Meglumin; Methylglucamin; Methylglucamine,Natural Products, buy Meglumine , Meglumine supplier , purchase Meglumine , Meglumine cost , Meglumine manufacturer , order Meglumine , high purity Meglumine

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: